Duke University: Prostatic Neoplasms trials

The registry lists 42 Prostatic Neoplasms studies with Duke University as lead sponsor. 4 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 4Phase 2 14No phase 24(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer TreatmentNot yet recruitingNCT07685249Not applicable
• Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate CancerRecruitingNCT07144228
• COMPASS Study for Metastatic Castration-resistant Prostate CancerRecruitingNCT07050433
• ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical TrialsRecruitingNCT06141993
• ARFI Imaging for Targeted Prostate BiopsyTerminatedNCT04607135Not applicableResults posted
• Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate CancerTerminatedNCT03964337Phase 2Results posted
• Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate CancerTerminatedNCT03111914Not applicableResults posted
• EXTEND Exercise TrialCompletedNCT02256111Phase 2Results posted
• Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)CompletedNCT02057939Phase 2Results posted
• Abiraterone Race in Metastatic Castrate-resistant Prostate CancerCompletedNCT01940276Phase 2Results posted
• Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate CancerCompletedNCT01717053Phase 2Results posted
• Stereotactic Body Radiotherapy (SBRT) for Prostate CancerCompletedNCT00941915Not applicableResults posted
• Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerTerminatedNCT00918385Phase 2Results posted
• Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate CancerTerminatedNCT00887640Phase 2Results posted
• Multimodality Phase II Study in Prostate CancerTerminatedNCT00734851Phase 2Results posted
• Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to ProstatectomyCompletedNCT00672594Phase 2Results posted
• Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)WithdrawnNCT04569461Phase 2
• Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)WithdrawnNCT04486846Not applicable
• Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
• Hypertension Management in Cancer PatientsTerminatedNCT03919214Not applicable
• A Survivorship Care Plan and Embedded Navigation ToolCompletedNCT03424837Not applicable
• Race-related Alternative Splicing: Novel Targets in Prostate CancerCompletedNCT03424213
• Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility StudyCompletedNCT03331458Not applicable
• CTC Immune CheckpointCompletedNCT02456571
• Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise TestingCompletedNCT02353715
• Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYCompletedNCT02269982
• Molecular Mechanisms Underlying Prostate Cancer DisparitiesCompletedNCT02229565
• Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerCompletedNCT02204943Early Phase 1
• Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate CancerCompletedNCT02036918Phase 1
• Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition BiologyWithdrawnNCT02022904Not applicable
• Carbohydrate Restriction and Prostate Cancer GrowthCompletedNCT01763944Not applicable
• Preoperative Radiation Therapy for High Risk Prostate CancerCompletedNCT01041326Phase 1
• Atkins Diet and Prostate Cancer Clinical TrialTerminatedNCT00932672Phase 2
• Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001CompletedNCT00636090
• Exercise Training Among Men With Prostate CancerWithdrawnNCT00620932Not applicable
• Coping in African American Prostate Cancer SurvivorsCompletedNCT00589966Not applicable
• Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightCompletedNCT00303875Phase 2
• Low-Fat Diet and/or Flaxseed in Preventing Prostate CancerCompletedNCT00049309Phase 2
• Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate CancerCompletedNCT00044980Not applicable
• Study of Health Promotion in Patients With Early-Stage Breast or Prostate CancerCompletedNCT00037024Not applicable
• Vaccine Therapy in Treating Patients With Metastatic Prostate CancerTerminatedNCT00010127Phase 1
• Vaccine Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00004211Phase 1/2